Answers are grounded in this paper and cite their sources.
Colorectal cancer (CRC) is associated with mucosal inflammation, immune dysregulation, and gut microbiota imbalance. This study evaluated the biological effects of whole green tea extract (GTE) using EGCG-focused network pharmacology, a syngeneic CT26 tumor model, and an AOM/DSS-induced colitis-associated CRC model. Oral GTE was related to a lower tumor burden, attenuated systemic wasting, and preserved intestinal mucosal architecture. Fecal microbiota and metabolite analyses showed GTE-associated changes in microbial composition, enrichment of selected SCFA-associated taxa, including Bacteroides and Parabacteroides, and increased fecal short-chain fatty acids. These changes were accompanied by lower circulating IL-1β, IL-6, and TNF-α, reduced neutrophil-associated inflammatory indices, and increased splenic CD8+ T-cell populations. Tumor analyses showed reduced VEGF and Bcl-2 and increased Bax expression. EGCG-associated targets were enriched in cancer-, inflammation-, apoptosis-, and VEGF-related pathways. These findings suggest that whole GTE is associated with parallel changes in host inflammatory and immune indices, fecal microbiota/SCFA profiles, and tumor-related outcomes.
No takes yet. Share an insight, caveat, or question.
Chang‐Jer Wu (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: